ImmuCell (ICCC) SEC Filings & 10K Form

$4.81
+0.01 (+0.21%)
(As of 05/17/2024 08:53 PM ET)

Recent ImmuCell SEC Filings

DateFilerForm TypeView
05/14/2024
3:05 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:06 PM
ImmuCell (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
8:00 AM
ImmuCell (Filer)
Form DEF 14A
04/09/2024
6:50 PM
ImmuCell (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
04/09/2024
6:52 PM
ImmuCell (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
04/09/2024
11:15 PM
ImmuCell (Filer)
Form EFFECT
04/09/2024
4:19 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
12:55 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
2:22 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
11:25 AM
ImmuCell (Issuer)
Tomsche David Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
1:49 PM
Gathagan Bryan K. (Reporting)
ImmuCell (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
8:04 AM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2023
1:28 PM
ImmuCell (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/11/2023
3:05 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2023
12:02 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
3:05 PM
ImmuCell (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ICCC) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners